COMPLIANCE: UAE Ministry of Health & Prevention, Französischer Dienst - öffentlich (CIR), NMPA (China GMP), EMA (EU-GMP), Gesundheit Kanada (Kanada GMP), Weltgesundheitsorganisation (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republik Korea GMP), FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), Halal-Forschungsrat, ECOVADIS, TGA (Australia GMP), TITCK (Turkish Health Authorities)
MÄRKTE: SFDA (Saudi Arabia), MFDS (South Korea), EDE (UAE), TGA (Australia), EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia)
OEB (Occupational Exposure Banding): 1 / low-hazard (PDE > 10,000 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/Tag), 4 / HPAPI (PDE = 10 - 100 µg/Tag)
THERAPEUTISCHE FACHGEBIETE (ATC): (A) Digestive tract and metabolism, (C) Cardiovascular system, (D) Dermatologicals
REGION: North America, Europe
BATCH-GRÖSSE: Klein, Mittel, Groß
KATEGORIE/PRODUKT: SERVICES, FDF / DRUG PRODUCTS, CHEMICAL-SYNTHETIC
DIENSTLEISTUNGEN: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
VERWENDUNG: Menschlich, Veterinär
